Trade TECX anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Tectonic Therapeutic, Inc. (TECX) is trading at US$30.75, up 2.77% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$735.64M. Over the past 52 weeks, TECX has traded between US$14.39 and US$39.53. On Syfe you can trade TECX with $0 commission and add it to your watchlist.
| Previous close | US$29.92 |
|---|---|
| Market cap | US$735.64M |
| 52-week range | US$14.39 – US$39.53 |
| Volume | 159.29K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Tectonic Therapeutic, Inc.
Tectonic Therapeutic, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of therapeutic proteins and antibodies that modulate the activity of G protein-coupled receptors (GPCR). It develops a proprietary technology platform called GEODe to enable the discovery and development of GPCR-targeted biologic medicines. The company was founded by Timothy A. Springer and Andrew Kruse in November 2015 and is headquartered in Watertown, MA.
Year: 2024
Tectonic Therapeutic Completes Enrollment in in Phase 2 Trial of TX45
Jun 10, 8:30 PM · MT Newswires
Tectonic Therapeutic Shares Rise After Raymond James Upgrade
May 26, 6:51 PM · MT Newswires
Raymond James Upgrades Tectonic Therapeutic to Strong Buy From Outperform, Adjusts PT to $81 From $76
May 26, 9:29 AM · MT Newswires
Tectonic Therapeutic, Inc. (TECX) stock is trading at US$30.75, +2.77% from the previous close of US$29.92.
The market cap for Tectonic Therapeutic, Inc. (TECX) stock is approximately US$735.64M.
The 52-week high for Tectonic Therapeutic, Inc. (TECX) stock is US$39.53.
The 52-week low for Tectonic Therapeutic, Inc. (TECX) stock is US$14.39.
Tectonic Therapeutic, Inc. (TECX) does not currently pay a dividend.
Stay on top of TECX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
